Medications for Severe Combined Immunodeficiency

13 results

  • asceniv - human immunoglobulin g liquid

    (Human Immunoglobulin G)
    Adma Biologics, Inc.
    Asceniv is a 10% intravenous immune globulin for treating primary humoral immunodeficiency (PI) in adults and adolescents aged 12–17, including congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
    Medication Details
    Drug Interactions

  • bivigam - immune globulin intravenous

    (Immune Globulin Intravenous (Human) 10%)
    Adma Biologics, Inc.
    BIVIGAM treats primary humoral immunodeficiency (PI) in adults and children 2 and older, including common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
    Medication Details
    Drug Interactions

  • cutaquig

    (Immunoglobulin G)
    Pfizer Laboratories Div Pfizer Inc
    Cutaquig is a subcutaneous immune globulin solution indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years and older, including CVID, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • cuvitru

    (Immune Globulin Subcutaneous (Human))
    Takeda Pharmaceuticals America, Inc.
    Cuvitru is an immune globulin subcutaneous solution indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and children 2 years and older, including CVID, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
    Medication Details
    Drug Interactions

  • flebogamma

    (Immune Globulin (Human))
    Grifols Usa, Llc
    Flebogamma 5% DIF treats primary immunodeficiency (PI) in adults and children 2 years and older, including common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.
    Medication Details
    Drug Interactions

  • gammagard liquid

    (Immune Globulin Infusion (Human))
    Takeda Pharmaceuticals America, Inc.
    Gammagard Liquid treats primary humoral immunodeficiency (PI) in adults and children 2+, improves muscle strength in adults with Multifocal Motor Neuropathy (MMN), and improves neuromuscular disability in adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
    Medication Details
    Drug Interactions

  • gammaplex

    (Human Immunoglobulin G)
    Bio Products Laboratory Ltd
    Gammaplex 10% is an intravenous immune globulin indicated for replacement therapy in primary humoral immunodeficiency (PI) in adults and children 2 years and older, and for treatment of chronic immune thrombocytopenic purpura (ITP) in adults to raise platelet counts.
    Medication Details
    Drug Interactions

  • gamunex-c

    (Immune Globulin (Human))
    Grifols Usa, Llc
    Gamunex-C treats primary humoral immunodeficiency (ages 2+), idiopathic thrombocytopenic purpura (ITP) in adults and children to raise platelet counts, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to improve neuromuscular function and prevent relapse.
    Medication Details
    Drug Interactions

  • hizentra

    (Human Immunoglobulin G)
    Csl Behring Ag
    Hizentra is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients aged 2 and older, and as maintenance therapy to prevent relapse of neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
    Medication Details
    Drug Interactions

  • hyqvia

    (Immune Globulin Infusion (Human), 10% With Recombinant Human Hyaluronidase)
    Takeda Pharmaceuticals America, Inc.
    HYQVIA treats Primary Immunodeficiency (PI) in adults and children 2+, including CVID, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. Also indicated as maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in adults to prevent relapse.
    Medication Details
    Drug Interactions